Editorial Transparency & Disclosure
How US Telehealth Review handles commercial relationships, why editorial rankings are determined exclusively by the v3.0 six-pillar rubric, and how material connections are disclosed in accordance with FTC 16 CFR Part 255.
How US Telehealth Review makes money
US Telehealth Review is operated by Ranika Editorial Group LLC, a Delaware limited liability company. We publish independent editorial reviews of U.S.-licensed telehealth providers offering GLP-1 medications, peptide therapies, longevity treatments, sexual-health programs, growth-hormone secretagogues, and recovery protocols.
Some links on US Telehealth Review are affiliate links. When a reader clicks an affiliate link and starts a paid program with a provider, we may receive a referral commission from that provider. Commissions are paid from the provider's marketing budget at no additional cost to the reader.
What affiliate commissions do not influence
- Editorial scores. Our v3.0 six-pillar scoring rubric is applied uniformly to every provider. Providers cannot pay to raise their score, change pillar weights, or remove a low score.
- Editor's Pick selection. The Editor's Pick badge is assigned by the editorial team based on weighted score plus qualitative review. NexLife is the current Editor's Pick for both semaglutide and tirzepatide because it scores 96/100 on our v3.0 rubric — the highest score in both categories. Editor's Pick selection is based on score plus qualitative editorial review, never on commercial relationship.
- Ranking order. Providers are listed in editorial rank order based on score. Affiliate status does not move a provider up or down the list.
- Trade-offs disclosure. Every NexLife card on US Telehealth Review includes a "Trade-offs to know" block. Trade-off disclosures cannot be removed or softened by any covered provider, regardless of commercial relationship.
- Coverage decisions. Whether we cover a provider, peptide, or program is an editorial decision based on reader interest, regulatory significance, and clinical relevance — not on whether the provider runs an affiliate program.
Material connections
If any covered provider has a material connection to the publisher of US Telehealth Review — including but not limited to common ownership, common management, paid sponsorship, referral compensation, or any other arrangement that would meet the FTC's definition of a material connection under 16 CFR Part 255 — that connection is disclosed here.
The publisher conducts editorial coverage of all providers using the same v3.0 six-pillar rubric regardless of commercial relationship. Material connections, where they exist, never change pillar weights, scoring methodology, Editor's Pick assignments, or the requirement that every provider card include a trade-offs disclosure.
Readers who believe a material connection is incompletely disclosed may write to editorial@ustelehealthreview.com; verified disclosure gaps are added to the corrections log.
Outbound editorial links may include UTM tracking parameters (utm_source, utm_medium, utm_campaign, utm_content) so the destination's analytics can attribute traffic. No reader-identifying information is transmitted through these parameters.
FTC compliance
This disclosure is provided in accordance with the United States Federal Trade Commission's "Guides Concerning the Use of Endorsements and Testimonials in Advertising" (16 CFR Part 255) and the FTC's "Disclosures 101 for Social Media Influencers" guidance. We aim to make our commercial relationships obvious, conspicuous, and easy to find.
Reader-funded alternative
If a reader prefers to support US Telehealth Review without using affiliate links, we accept reader donations through the contact channels on our contact page. Donations do not influence editorial coverage.
Questions or corrections
If a reader believes any disclosure on US Telehealth Review is incomplete or misleading, please contact our editor at editorial@ustelehealthreview.com. Verified disclosure gaps are added to the corrections log.